PTEN and breast carcinoma: Incubation with exosomes from doxorubicin-resistant breast cancer cells or knockdown of PTEN enhanced the resistance of breast cancer cells to doxorubicin, which was prevented by the treatment of miR-3613-5p inhibitor.